Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) has resulted in a catastrophic pandemic and …

The world is striving against the severe crisis of the COVID-19 pandemic. Healthcare
professionals are struggling to treat their patients based on nonspecific therapies. Amidst …

Background: The rapidly evolving coronavirus disease 2019 (COVID-19) has resulted in
more than 24 million infections and 821 thousand deaths. However, a vaccine or specific …

Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has infected approximately
6.5 million people, with a loss of over 383,000 lives across the globe (as of 03 June 2020) …

The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China
led to a public health emergency of international concern, putting all health organizations on …

Abstract Coronavirus disease 2019 (COVID-19) has become a world pandemic since early
2020. Currently, there is no established treatment to combat this potentially fatal disease …

The recent emergence of coronavirus disease 2019 (COVID‐19) pandemic has reassessed
the usefulness of historic convalescent plasma transfusion (CPT). This review was …

The world is passing through a very difficult phase due to the coronavirus disease 2019
(COVID-19) pandemic, which has disrupted almost all spheres of life. Globally, according to …

Importance/Background: With a scarcity of high-grade evidence for COVID-19 treatment,
researchers and health care providers across the world have resorted to classical and …

Conclusion: CP might be an effective therapy for severe COVID-19 patients. HIGHLIGHTS
Currently, no specific antiviral drug has been approved to target novel coronavirus …